Article thumbnail

Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves

By Damien Vitour, Jean Guillotin, Corinne Sailleau, Cyril Viarouge, Alexandra Desprat, Frédéric Wolff, Guillaume Belbis, Benoit Durand, Labib Bakkali-Kassimi, Emmanuel Breard, Stéphan Zientara and Gina Zanella

Abstract

Since its introduction into northern Europe in 2006, bluetongue has become a major threat to animal health. While the efficacy of commercial vaccines has been clearly demonstrated in livestock, little is known regarding the effect of maternal immunity on vaccinal efficacy. Here, we have investigated the duration and amplitude of colostral antibody-induced immunity in calves born to dams vaccinated against bluetongue virus serotype 8 (BTV-8) and the extent of colostral antibody-induced interference of vaccination in these calves. Twenty-two calf-cow pairs were included in this survey. The median age at which calves became seronegative for BTV was 84 and 112 days as assayed by seroneutralisation test (SNT) and VP7 BTV competitive ELISA (cELISA), respectively. At the mean age of 118 days, 13/22 calves were immunized with inactivated BTV-8 vaccine. In most calves vaccination elicited a weak immune response, with seroconversion in only 3/13 calves. The amplitude of the humoral response to vaccination was inversely proportional to the maternal antibody level prior to vaccination. Thus, the lack of response was attributed to the persistence of virus-specific colostral antibodies that interfered with the induction of the immune response. These data suggest that the recommended age for vaccination of calves born to vaccinated dams needs to be adjusted in order to optimize vaccinal efficacy

Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3042407
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1995). Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves.
  2. (2010). CA: Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine. Vaccine
  3. (2009). CA: Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine
  4. (2004). Caporale V: Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2. Vet Ital
  5. (2009). Core Team: R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing;
  6. (2006). Dochy JM: Bluetongue in northern Europe. Vet Rec
  7. (2009). Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine
  8. (1991). EG: The role of passive immunity in bovine respiratory syncytial virus-infected calves.
  9. (2002). EJ: Bluetongue virus in the Mediterranean Basin 1998-2001. Vet J
  10. (2008). Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. Prev Vet Med
  11. (1998). JA: Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus. J Am Vet Med Assoc
  12. (1975). Lascelles AK: Antibody responses to neonatal immunisation in calves. Res Vet Sci
  13. (1985). Meiske JC: Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines.
  14. (1978). Meiske JC: Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.
  15. (2007). Oura CA: Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet Rec
  16. (1989). Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet Microbiol
  17. (2008). PS: Bluetongue epidemiology in the European Union. Emerg Infect Dis
  18. (1996). PS: Effects of perinatal vaccination on humoral and cellular immune responses in cows and young calves.
  19. (1976). RC: Failure of colostral immunoglobulin transfer in calves dying from infectious disease. JA m Vet Med Assoc
  20. (2000). RD: Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med
  21. (2008). Rijn PA: Performance of clinical signs to detect bluetongue virus serotype 8 outbreaks in cattle and sheep during the 2006-epidemic in The Netherlands. Vet Microbiol
  22. (2008). S: Bluetongue virus: virology, pathogenesis and immunity. Vet Res
  23. (2008). S: Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis
  24. (2003). Veterinary epidemiologic research